SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 1,535.18 |
| Enterprise Value ($M) | 1,765.32 |
| Book Value ($M) | 1,249.03 |
| Book Value / Share | 7.44 |
| Price / Book | 1.23 |
| NCAV ($M) | -1,016.68 |
| NCAV / Share | -6.06 |
| Price / NCAV | -1.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | -0.11 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.69 |
| Current Ratio | 4.37 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 604.56 |
| Assets | 2,870.27 |
| Liabilities | 1,621.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1,186.49 |
| Operating Income | 92.49 |
| Net Income | -155.10 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 271.79 |
| Cash from Investing | -206.62 |
| Cash from Financing | -33.44 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Nomura Holdings Inc | 4.90 | -30.75 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| SYBE – Sybleu Inc. | TBEV – High Performance Beverages Company |
| TBIO – Telesis Bio, Inc. | TEVJF – Teva Pharmaceutical Industries Limited |
| THER – Theralink Technologies, Inc. |
Financial data and stock pages provided by
Fintel.io